Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to address that disease,” Colin Murdoch, Isomorphic Labs president and Google ...

Isomorphic Labs, a drug discovery company spun out of Google DeepMind, is about to make a historic breakthrough ... DeepMind’s revolutionary AlphaFold AI system gave birth to Isomorphic Labs, which ...

Isomorphic Labs is a London-based drug developer that’s owned and operated by Alphabet Inc. The company was founded in 2021 as an offshoot from DeepMind , Google’s multidisciplinary AI ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. As Chief Medical Officer, Dr. Wolf will bring ...

For the first of these tasks Dr Baker and his colleagues use RF diffusion, an AI model they have developed to predict a ...